(Q40982885)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

Ying-Huang Tsai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Meng-Jer Hsieh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Yu-Wen Wen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Han-Chung Hu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Yen-Nan Chao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Cheng-Ta Yang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Chung-Chi Huang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

English

0 references

publication date

30 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

2897-2902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936662%20AND%20SRC:MED&resulttype=core&format=json

Community-acquired pneumonia

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Inefficacy of pneumococcal vaccine in a high-risk population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Pneumococcal vaccination in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Taiwan's new national health insurance program: genesis and experience so far.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Vaccines for preventing pneumococcal infection in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

National surveillance of invasive pneumococcal diseases in Taiwan, 2008-2012: differential temporal emergence of serotype 19A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

Pneumococcal polysaccharide revaccination: immunoglobulin g seroconversion, persistence, and safety in frail, chronically ill older subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068

New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.068